NANOBIOTIX (EPA:NANO) | WebDisclosure

Basculer en Français

10836	Companies
235277	Keywords
164215	Articles
126032	Press releases

Home
Companies
NANOBIOTIX

BRIEF

published on 10/01/2025 at 22:20, 10 months 13 days ago

NANOBIOTIX révèle des résultats prometteurs d'une étude de phase 1 pour le traitement du cancer de l'œsophage

Étude De Phase 1 Radiothérapie JNJ-1900 (NBTXR3) Cancer De L'œsophage Événements Indésirables
PRESS RELEASE

published on 10/01/2025 at 22:15, 10 months 13 days ago

NANOBIOTIX Announces First Data From Phase 1 Study Evaluating JNJ-1900 (NBTXR3) for Patients With Esophageal Cancer
Nanobiotix announces first data from Phase 1 study evaluating JNJ-1900 (NBTXR3) for patients with esophageal cancer. Results presented at ASTRO 2025 Annual Meeting

NANOBIOTIX Phase 1 Study JNJ-1900 Esophageal Cancer ASTRO
PRESS RELEASE

published on 10/01/2025 at 22:15, 10 months 13 days ago

NANOBIOTIX annonce les premières données de Phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage
Nanobiotix annonce les premières données de phase 1 évaluant JNJ-1900 (NBTXR3) chez des patients atteints de cancer de l’œsophage. Taux de contrôle de la maladie de 85% et taux de réponse objective de 69%

NANOBIOTIX Phase 1 JNJ-1900 ASTRO Cancer De L’œsophage
PRESS RELEASE

published on 09/30/2025 at 22:27, 10 months 14 days ago

RAPPORT FINANCIER SEMESTRIEL
BRIEF

published on 09/30/2025 at 22:20, 10 months 14 days ago

Nanobiotix : Bilan financier et avancées cliniques au 1er semestre 2025

Résultats Financiers Biotechnologie NANOBIOTIX Johnson & Johnson JNJ-1900
BRIEF

published on 09/30/2025 at 22:20, 10 months 14 days ago

Nanobiotix: Financial results and clinical progress in the first half of 2025

Financial Results Biotechnology NANOBIOTIX Johnson & Johnson JNJ-1900
PRESS RELEASE

published on 09/30/2025 at 22:15, 10 months 14 days ago

NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025
Nanobiotix fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2025, marqué par le développement clinique de JNJ-1900 et une gestion financière rigoureuse

Résultats Financiers Développement Clinique Gestion Financière NANOBIOTIX JNJ-1900
PRESS RELEASE

published on 09/30/2025 at 22:15, 10 months 14 days ago

NANOBIOTIX Provides Business Update and Reports Half Year 2025 Financial Results
Nanobiotix provides business update & reports 2025 half year financial results. Highlights clinical development program & financial performance

Financial Results Financial Performance Business Update Clinical Development NANOBIOTIX
BRIEF

published on 09/30/2025 at 00:35, 10 months 15 days ago

NANOBIOTIX Reports Promising Phase 1 Results for JNJ-1900 (NBTXR3) in R/M-HNSCC

Phase 1 Trial NANOBIOTIX Clinical Study Results R/M-HNSCC JNJ-1900 (NBTXR3)
BRIEF

published on 09/30/2025 at 00:35, 10 months 15 days ago

NANOBIOTIX annonce des résultats prometteurs de phase 1 pour JNJ-1900 (NBTXR3) dans le traitement du carcinome épidermoïde œsophagien (HNSCC) métastatique (R/M)

NANOBIOTIX Essai De Phase 1 Résultats Des Études Cliniques R/M-HNSCC JNJ-1900 (NBTXR3)

Accesswire

Published on 08/15/2026 at 00:50, 18 hours 4 minutes ago

Revive Therapeutics Reports Grant of Options
Published on 08/15/2026 at 00:15, 18 hours 39 minutes ago

Full Circle Lithium Announces Closing of Private Placement
Published on 08/14/2026 at 23:45, 19 hours 9 minutes ago

AI/ML Innovations Inc. Announces Proposed Private Placement
Published on 08/14/2026 at 23:25, 19 hours 29 minutes ago

NuRAN Wireless Closes $7.6 Million Financing
Published on 08/14/2026 at 23:00, 19 hours 54 minutes ago

Medicure Reports Financial Results for Quarter Ended June 30, 2026 and Schedules August 17, 2026 Conference Call

View all ACCESSWIRE

EQS Group

Published on 08/15/2026 at 15:05, 3 hours 48 minutes ago

Brook Gaming Officially Launches Sniper 2 Flagship Keyboard and Mouse Converter for Cross-Platform Console Gaming
Published on 08/15/2026 at 08:05, 10 hours 48 minutes ago

SKYWORTH Solar to Launch SolaMate Balcony Solar System on Joybuy Germany on August 15
Published on 08/14/2026 at 18:29, 1 day ago

Designated Persons Notifications
Published on 08/14/2026 at 18:29, 1 day ago

Designated Persons Notifications
Published on 08/14/2026 at 18:15, 1 day ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 08/13/2026 at 18:00, 2 days ago

Chiffre d’affaires du 1er trimestre 2026-27 : 14,4 M€
Published on 08/11/2026 at 17:45, 4 days 1 hour ago

DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 4 days 1 hour ago

Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 5 days ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 5 days ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026

View all LES ECHOS COMFI WIRE